Idiopathic pulmonary fibrosis
L Richeldi, HR Collard, MG Jones - The Lancet, 2017 - thelancet.com
Idiopathic pulmonary fibrosis is a prototype of chronic, progressive, and fibrotic lung disease.
Healthy tissue is replaced by altered extracellular matrix and alveolar architecture is …
Healthy tissue is replaced by altered extracellular matrix and alveolar architecture is …
Palliative care in interstitial lung disease: living well
M Kreuter, E Bendstrup, AM Russell… - The Lancet …, 2017 - thelancet.com
Progressive fibrotic interstitial lung diseases (ILDs) are characterised by major reductions in
quality of life and survival and have similarities to certain malignancies. However, palliative …
quality of life and survival and have similarities to certain malignancies. However, palliative …
Do patients want to die at home? A systematic review of the UK literature, focused on missing preferences for place of death
Background End-of-life care policy has a focus on enabling patients to die in their preferred
place; this is believed for most to be home. This review assesses patient preferences for …
place; this is believed for most to be home. This review assesses patient preferences for …
Palliative care and location of death in decedents with idiopathic pulmonary fibrosis
KO Lindell, Z Liang, LA Hoffman, MQ Rosenzweig… - Chest, 2015 - Elsevier
BACKGROUND Palliative care, integrated early, may reduce symptom burden in patients
with idiopathic pulmonary fibrosis (IPF). However, limited information exists on timing and …
with idiopathic pulmonary fibrosis (IPF). However, limited information exists on timing and …
The palliative care needs for fibrotic interstitial lung disease: a qualitative study of patients, informal caregivers and health professionals
Background: While there have been some studies looking at the impact on quality of life of
patients with idiopathic pulmonary fibrosis, to date no qualitative research looking at the …
patients with idiopathic pulmonary fibrosis, to date no qualitative research looking at the …
Unmet needs in the treatment of idiopathic pulmonary fibrosis―insights from patient chart review in five European countries
TM Maher, M Molina-Molina, AM Russell… - BMC pulmonary …, 2017 - Springer
Background Two antifibrotic drugs, pirfenidone and nintedanib, are approved by the
European Medicines Agency and the US Food and Drug Administration for the treatment of …
European Medicines Agency and the US Food and Drug Administration for the treatment of …
Palliative care for patients with advanced fibrotic lung disease: a randomised controlled phase II and feasibility trial of a community case conference intervention
Background Those affected by advanced fibrotic interstitial lung diseases (ILDs) have
considerable unmet symptom and psychological needs. Case conferencing has been …
considerable unmet symptom and psychological needs. Case conferencing has been …
End-of-life care in oxygen-dependent ILD compared with lung cancer: a national population-based study
Z Ahmadi, NG Wysham, S Lundström, C Janson… - Thorax, 2016 - thorax.bmj.com
Rationale Advanced fibrosing interstitial lung disease (ILD) is often progressive and
associated with a high burden of symptoms and poor prognosis. Little is known about the …
associated with a high burden of symptoms and poor prognosis. Little is known about the …
End-of-life care of patients with idiopathic pulmonary fibrosis
K Rajala, JT Lehto, M Saarinen, E Sutinen, T Saarto… - BMC palliative …, 2016 - Springer
Background Idiopathic pulmonary fibrosis (IPF) is a progressive disease with median
survival from 2 to 7 years. Palliative care is an important part of patients´ care as lung …
survival from 2 to 7 years. Palliative care is an important part of patients´ care as lung …
Inadequate palliative care in chronic lung disease. An issue of health care inequality
Patients with chronic lung diseases suffer higher symptom burden, lower quality of life, and
greater social isolation compared with patients with other diagnoses, such as cancer. These …
greater social isolation compared with patients with other diagnoses, such as cancer. These …